| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.043 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |